Novo-Passit, 60 pcs.

Pharmacotherapeutic group

Sedative of herbal origin

ATX code: N05CM

Pharmacological action

It is a combined medicine, the pharmacological activity of which is due to its constituent herbal extract components with predominantly sedative (sedative) action and guaifenesin, which has anxiolytic (anti-anxiety) effect.

Indications

Active ingredient

Composition

Active ingredients:

New Passita extract dry (1:6.5) (obtained from valerian medicinal rhizomes with roots (5 parts), lemon balm herb (2 parts), St. John’s wort herb (5 parts), hawthorn leaves and flowers (5 parts), Passiflora incarnata herb (1 part), common hops (5 parts), black elderflower (2 parts)) 157.5 mg; guaifenesin 200.0 mg

Supplementary substances:

Silica dioxide 2.0 mg, microcrystalline cellulose 96.0 mg, glyceryl tribegenate 10.0 mg, magnesium stearate 10.0 mg, lactose monohydrate up to 800.0 mg

Shell:

Opadray “AMB 80W31115” green (polyvinyl alcohol 45.52%, titanium dioxide 26.5%, talc 20.0%, soy lecithin 2.0%, xanthan gum 0.48%, quinoline yellow dye 2.5%, iron oxide yellow dye 2.0%, indigo carmine dye 1.0%) 24.0 mg.

How to take, the dosage

Interaction

When taking Novo-PassitÒ and other drugs at the same time, their effect may be enhanced or weakened. Before starting to take the drug simultaneously with other medicines, you should consult your doctor.

The drug increases the effect of alcohol and other substances that depress the central nervous system.

Medications used to relax skeletal muscles (central myorelaxation) may increase the risk of side effects of the drug, especially muscle weakness.

The Hypericum extract contained in the drug reduces the effectiveness of hormonal contraception, as well as of medicines used mainly after transplantation to reduce the risk of rejection of the transplanted organ or tissue (immunosuppressive drugs), medicines for AIDS treatment, cardiovascular diseases, bronchial diseases and prevention of thromboembolism. Therefore, before starting Novo-PassitÒ against the background of these drugs, it is necessary to consult a doctor.

Special Instructions

Alcoholic beverages should not be consumed during treatment with the drug.

When taking Novo-PassitÒ, especially in patients with fair skin, avoid exposure to ultraviolet radiation (prolonged exposure to direct sunlight, visiting a solarium).

If symptoms persist or worsen after 7 days of treatment, the patient’s physician should be told.

Influence on ability to drive and operate machinery

When using the drug, one should refrain from performing potentially hazardous activities requiring increased concentration and quick psychomotor reactions (including driving vehicles and operating moving machinery).

Contraindications

Hypersensitivity to the components of the drug, especially to guaifenesin, lactose intolerance, lactase deficiency, glucose-galactose malabsorption, myasthenia, children under 12 years of age.

With caution

Acute gastrointestinal diseases, liver disease, alcoholism, brain disease or injury, epilepsy, children over 12 years of age.

Side effects

Overdose

Pregnancy use